{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:58:59Z","timestamp":1779375539848,"version":"3.53.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1122-y","type":"journal-article","created":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T20:33:39Z","timestamp":1475699619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study"],"prefix":"10.1186","volume":"18","author":[{"given":"Claudio","family":"Corallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cutolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Kahaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Pecetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Montella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Chirico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Soldano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranuccio","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,6]]},"reference":[{"key":"1122_CR1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7861\/clinmedicine.16-1-55","volume":"16","author":"CP Denton","year":"2016","unstructured":"Denton CP. Advances in pathogenesis and treatment of systemic sclerosis. Clin Med (Lond). 2016;16:55\u201360.","journal-title":"Clin Med (Lond)"},{"key":"1122_CR2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1586\/eci.11.35","volume":"7","author":"M Cutolo","year":"2011","unstructured":"Cutolo M, Sulli A, Smith V. Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover? Expert Rev Clin Immunol. 2011;7:395\u20137.","journal-title":"Expert Rev Clin Immunol"},{"key":"1122_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nrrheum.2014.222","volume":"11","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Distler O. Systemic sclerosis in 2014: advances in cohort enrichment shape future of trial design. Nat Rev Rheumatol. 2015;11:72\u20134.","journal-title":"Nat Rev Rheumatol"},{"key":"1122_CR4","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","volume":"65","author":"M Matucci-Cerinic","year":"2013","unstructured":"Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum. 2013;65:1953\u201362.","journal-title":"Arthritis Rheum"},{"key":"1122_CR5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/ard.55.2.122","volume":"55","author":"AL Herrick","year":"1996","unstructured":"Herrick AL, Illingworth K, Blann A. von Willebrand factor, thrombomodulin, thromboxane, thromboglobulin and markers of fibrinolysis in primary Raynaud\u2019s phenomenon and systemic sclerosis. Ann Rheum Dis. 1996;55:122\u201327.","journal-title":"Ann Rheum Dis"},{"key":"1122_CR6","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3899\/jrheum.150088","volume":"42","author":"P Cipriani","year":"2015","unstructured":"Cipriani P, Di Benedetto P, Ruscitti P, Capece D, Zazzeroni F, Liakouli V, et al. The endothelial-mesenchymal transition in systemic sclerosis is induced by endothelin-1 and transforming growth factor-\u03b2 and may be blocked by macitentan, a dual endothelin-1 receptor antagonist. J Rheumatol. 2015;42:1808\u201316.","journal-title":"J Rheumatol"},{"key":"1122_CR7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s13075-014-0442-z","volume":"16","author":"P Cipriani","year":"2014","unstructured":"Cipriani P, Di Benedetto P, Ruscitti P, Campese AF, Liakouli V, Carubbi F, et al. Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features. Arthritis Res Ther. 2014;16:442.","journal-title":"Arthritis Res Ther"},{"key":"1122_CR8","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ajpath.2011.06.001","volume":"179","author":"S Piera-Velazquez","year":"2011","unstructured":"Piera-Velazquez S, Li Z, Jimenez SA. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol. 2011;179:1074\u201380.","journal-title":"Am J Pathol"},{"key":"1122_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/jcm5040045","volume":"5","author":"S Piera-Velazquez","year":"2016","unstructured":"Piera-Velazquez S, Mendoza FA, Jimenez SA. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of human fibrotic diseases. J Clin Med. 2016;5:45.","journal-title":"J Clin Med"},{"key":"1122_CR10","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1172\/JCI82719","volume":"125","author":"PY Chen","year":"2015","unstructured":"Chen PY, Qin L, Baeyens N, Li G, Afolabi T, Budatha M, et al. Endothelial-to-mesenchymal transition drives atherosclerosis progression. J Clin Invest. 2015;125:4514\u201328.","journal-title":"J Clin Invest"},{"key":"1122_CR11","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1152\/ajplung.00378.2006","volume":"293","author":"E Arciniegas","year":"2007","unstructured":"Arciniegas E, Frid MG, Douglas IS, Stenmark KR. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2007;293:L1\u20138.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1122_CR12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1440-1797.2010.01319.x","volume":"15","author":"J Li","year":"2010","unstructured":"Li J, Bertram JF. Endothelial-myofibroblast transition, a new player in diabetic renal fibrosis. Nephrology (Carlton). 2010;15:507\u201312.","journal-title":"Nephrology (Carlton)"},{"key":"1122_CR13","doi-asserted-by":"crossref","first-page":"19452","DOI":"10.1074\/jbc.M109.011833","volume":"284","author":"Y Fu","year":"2009","unstructured":"Fu Y, Chang A, Chang L, Niessen K, Eapen S, Setiadi A, et al. Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells. J Biol Chem. 2009;284:19452\u201362.","journal-title":"J Biol Chem"},{"key":"1122_CR14","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","volume":"67","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 2007;67:10123\u20138.","journal-title":"Cancer Res"},{"key":"1122_CR15","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","volume":"10","author":"R Lafyatis","year":"2014","unstructured":"Lafyatis R. Transforming growth factor \u03b2\u2014at the centre of systemic sclerosis. Nat Rev Rheumatol. 2014;10:706\u201319.","journal-title":"Nat Rev Rheumatol"},{"key":"1122_CR16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.lfs.2013.12.024","volume":"118","author":"F Rodr\u00edguez-Pascual","year":"2014","unstructured":"Rodr\u00edguez-Pascual F, Busnadiego O, Gonz\u00e1lez-Santamar\u00eda J. The profibrotic role of endothelin-1: is the door still open for the treatment of fibrotic diseases? Life Sci. 2014;118:156\u201364.","journal-title":"Life Sci"},{"key":"1122_CR17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1476-5381.2012.02190.x","volume":"168","author":"AS Ahmedat","year":"2013","unstructured":"Ahmedat AS, Warnken M, Seemann WK, Mohr K, Kostenis E, Juergens UR, et al. Pro-fibrotic processes in human lung fibroblasts are driven by an autocrine\/paracrine endothelinergic system. Br J Pharmacol. 2013;168:471\u201387.","journal-title":"Br J Pharmacol"},{"key":"1122_CR18","first-page":"202","volume":"15","author":"EC Leroy","year":"1988","unstructured":"Leroy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger Jr TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202\u20135.","journal-title":"J Rheumatol"},{"key":"1122_CR19","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"1122_CR20","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/art.1780330828","volume":"33","author":"PJ Clements","year":"1990","unstructured":"Clements PJ, Lachenruch PA, Nq SC, Simmons M, Sterz M, Furst DE. Skin score: a semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum. 1990;33:1256\u201363.","journal-title":"Arthritis Rheum"},{"key":"1122_CR21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:48\u2013254.","journal-title":"Anal Biochem"},{"key":"1122_CR22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680\u20135.","journal-title":"Nature"},{"key":"1122_CR23","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/01.RES.0000021432.70309.28","volume":"90","author":"MG Frid","year":"2002","unstructured":"Frid MG, Kale VA, Stenmark KR. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res. 2002;90:1189\u201396.","journal-title":"Circ Res"},{"key":"1122_CR24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1242\/jcs.103.2.521","volume":"103","author":"E Arciniegas","year":"1992","unstructured":"Arciniegas E, Sutton AB, Allen TD, Schor AM. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci. 1992;103:521\u20139.","journal-title":"J Cell Sci"},{"issue":"Suppl 5","key":"1122_CR25","doi-asserted-by":"crossref","first-page":"v14","DOI":"10.1093\/rheumatology\/ken279","volume":"47","author":"B Kahaleh","year":"2008","unstructured":"Kahaleh B. The microvascular endothelium in scleroderma. Rheumatology (Oxford). 2008;47 Suppl 5:v14\u20135.","journal-title":"Rheumatology (Oxford)"},{"key":"1122_CR26","doi-asserted-by":"crossref","first-page":"835948","DOI":"10.1155\/2013\/835948","volume":"2013","author":"SA Jimenez","year":"2013","unstructured":"Jimenez SA. Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis. ISRN Rheumatol. 2013;2013:835948.","journal-title":"ISRN Rheumatol"},{"key":"1122_CR27","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/annrheumdis-2012-203183","volume":"72","author":"M Manetti","year":"2013","unstructured":"Manetti M, Guiducci S, Romano E, Bellando-Randone S, Lepri G, Bruni C, et al. Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis. Ann Rheum Dis. 2013;72:1425\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1122_CR28","doi-asserted-by":"crossref","first-page":"e35231","DOI":"10.1371\/journal.pone.0035231","volume":"7","author":"S Harris","year":"2012","unstructured":"Harris S, Craze M, Newton J, Fisher M, Shima DT, Tozer GM, et al. Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale. PLoS One. 2012;7:e35231.","journal-title":"PLoS One"},{"key":"1122_CR29","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","volume":"109","author":"M Manetti","year":"2011","unstructured":"Manetti M, Guiducci S, Romano E, Ceccarelli C, Bellando-Randone S, Conforti ML, et al. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis. Circ Res. 2011;109:e14\u201326.","journal-title":"Circ Res"},{"key":"1122_CR30","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2013-203706","volume":"73","author":"M Manetti","year":"2014","unstructured":"Manetti M, Rosa I, Milia AF, Guiducci S, Carmeliet P, Ibba-Manneschi L, et al. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? Ann Rheum Dis. 2014;73:1700\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1122_CR31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.39421","volume":"68","author":"FA Mendoza","year":"2016","unstructured":"Mendoza FA, Piera-Velazquez S, Farber JL, Feghali-Bostwick C, Jim\u00e9nez SA. Endothelial cells expressing endothelial and mesenchymal cell gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease. Arthritis Rheumatol. 2016;68:210\u20137.","journal-title":"Arthritis Rheumatol"},{"key":"1122_CR32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/annrheumdis-2013-eular.595","volume":"72 Suppl 3","author":"S Soldano","year":"2013","unstructured":"Soldano S, Montagna P, Brizzolara R, Seriolo B, Sulli A, Cutolo M. Endothelial-to- mesenchymal transition in cultured human dermal microvascular endothelial cells: effects of endothelin-1 [abstract]. Ann Rheum Dis. 2013;72 Suppl 3:186.","journal-title":"Ann Rheum Dis"},{"key":"1122_CR33","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.27307","volume":"62","author":"D Lagares","year":"2010","unstructured":"Lagares D, Garc\u00eda-Fern\u00e1ndez RA, Jim\u00e9nez CL, Mag\u00e1n-Marchal N, Busnadiego O, Lamas S, et al. Endothelin 1 contributes to the effect of transforming growth factor \u03b21 on wound repair and skin fibrosis. Arthritis Rheum. 2010;62:878\u201389.","journal-title":"Arthritis Rheum"},{"key":"1122_CR34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13075-015-0754-7","volume":"17","author":"P Cipriani","year":"2015","unstructured":"Cipriani P, Di Benedetto P, Ruscitti P, Verzella D, Fischietti M, Zazzeroni F, et al. Macitentan inhibits the transforming growth factor-\u03b2 profibrotic action, blocking the signaling mediated by the ETR\/T\u03b2RI complex in systemic sclerosis dermal fibroblasts. Arthritis Res Ther. 2015;17:247.","journal-title":"Arthritis Res Ther"},{"key":"1122_CR35","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1111\/j.1742-4658.2005.05016.x","volume":"272","author":"A Horstmeyer","year":"2005","unstructured":"Horstmeyer A, Licht C, Scherr G, Eckes B, Krieg T. Signalling and regulation of collagen I synthesis by ET-1 and TGF-beta1. FEBS J. 2005;272:6297\u2013309.","journal-title":"FEBS J"},{"key":"1122_CR36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrrheum.2015.111","volume":"11","author":"M Cutolo","year":"2015","unstructured":"Cutolo M, Sulli A. Therapy: optimized treatment algorithms for digital vasculopathy in SSc. Nat Rev Rheumatol. 2015;11:569\u201371.","journal-title":"Nat Rev Rheumatol"},{"key":"1122_CR37","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1128\/MCB.00625-06","volume":"26","author":"X Shi-Wen","year":"2006","unstructured":"Shi-Wen X, Rodr\u00edguez-Pascual F, Lamas S, Holmes A, Howat S, Pearson JD, et al. Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors. Mol Cell Biol. 2006;26:5518\u201327.","journal-title":"Mol Cell Biol"},{"key":"1122_CR38","first-page":"18","volume":"41","author":"M Cutolo","year":"2016","unstructured":"Cutolo M, Sulli A, Pizzorni C, Paolino S, Smith V. Systemic sclerosis: markers and targeted treatments. Acta Reumatol Port. 2016;41:18\u201325.","journal-title":"Acta Reumatol Port"},{"key":"1122_CR39","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/jpet.108.142976","volume":"327","author":"M Iglarz","year":"2008","unstructured":"Iglarz M, Binkert C, Morrison K, Fischli W, Gatfield J, Treiber A, et al. Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist. J Pharmacol Exp Ther. 2008;327:736\u201345.","journal-title":"J Pharmacol Exp Ther"},{"key":"1122_CR40","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ajpath.2015.03.019","volume":"185","author":"RB Good","year":"2015","unstructured":"Good RB, Gilbane AJ, Trinder SL, Denton CP, Coghlan G, Abraham DJ, et al. Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension. Am J Pathol. 2015;185:1850\u20138.","journal-title":"Am J Pathol"},{"key":"1122_CR41","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/CIRCULATIONAHA.114.008750","volume":"131","author":"B Ranchoux","year":"2015","unstructured":"Ranchoux B, Antigny F, Rucker-Martin C, Hautefort A, P\u00e9choux C, Bogaard HJ, et al. Endothelial-to-mesenchymal transition in pulmonary hypertension. Circulation. 2015;131:1006\u201318.","journal-title":"Circulation"},{"key":"1122_CR42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.matbio.2016.01.012","volume":"51","author":"SA Jimenez","year":"2016","unstructured":"Jimenez SA, Piera-Velazquez S. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of systemic sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension: myth or reality? Matrix Biol. 2016;51:26\u201336.","journal-title":"Matrix Biol"},{"key":"1122_CR43","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/jama.2016.5258","volume":"15","author":"D Khanna","year":"2016","unstructured":"Khanna D, Denton CP, Merkel PA, Krieg T, Le Brun FO, Marr A, et al. Effect of macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: DUAL-1 and DUAL-2 randomized clinical trials. JAMA. 2016;15:1975\u201388.","journal-title":"JAMA"},{"key":"1122_CR44","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s10067-012-2074-5","volume":"31","author":"S Guiducci","year":"2012","unstructured":"Guiducci S, Bellando Randone S, Bruni C, Carnesecchi G, Maresta A, Iannone F, et al. Bosentan fosters microvascular de-remodelling in systemic sclerosis. Clin Rheumatol. 2012;31:1723\u20135.","journal-title":"Clin Rheumatol"},{"key":"1122_CR45","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3899\/jrheum.131284","volume":"41","author":"M Cutolo","year":"2014","unstructured":"Cutolo M, Ruaro B, Pizzorni C, Ravera F, Smith V, Zampogna G, et al. Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. J Rheumatol. 2014;41:881\u20136.","journal-title":"J Rheumatol"},{"key":"1122_CR46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3899\/jrheum.120416","volume":"40","author":"M Cutolo","year":"2013","unstructured":"Cutolo M, Zampogna G, Vremis L, Smith V, Pizzorni C, Sulli A. Longterm effects of endothelin receptor antagonism on microvascular damage evaluated by nailfold capillaroscopic analysis in systemic sclerosis. J Rheumatol. 2013;40:40\u20135.","journal-title":"J Rheumatol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1122-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T21:10:58Z","timestamp":1749589858000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1122-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,6]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1122"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1122-y","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726822633.793524728","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,6]]},"article-number":"228"}}